IL161347A0 - Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage - Google Patents

Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage

Info

Publication number: IL161347A0
Authority: IL; Israel
Prior art keywords: imidazol; phenyl; substituted; piperidine derivatives; ischaemic damage
Prior art date: 2001-10-15

Application number

IL16134702A

Other languages

English (en)

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-15

Filing date

2002-10-10

Publication date

2004-09-27

2002-10-10 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2004-09-27 Publication of IL161347A0 publication Critical patent/IL161347A0/xx

Links

GBANLFWFVPIRMO-UHFFFAOYSA-N 4-(1h-imidazol-2-yl)-4-phenylpiperidine Chemical class C1CNCCC1(C=1C=CC=CC=1)C1=NC=CN1 GBANLFWFVPIRMO-UHFFFAOYSA-N 0.000 title 1
230000000302 ischemic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IL16134702A 2001-10-15 2002-10-10 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage IL161347A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01203927		2001-10-15
PCT/EP2002/011371 WO2003039440A2 (fr)	2001-10-15	2002-10-10	Derives de 4-phenyl-4-(1h-imidazol-2-yl)-piperidine substituee utiles pour reduire les lesions ischemiques

Publications (1)

Publication Number	Publication Date
IL161347A0 true IL161347A0 (en)	2004-09-27

Family

ID=8181081

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16134702A IL161347A0 (en)	2001-10-15	2002-10-10	Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage

Country Status (26)

Country	Link
US (1)	US7390822B2 (fr)
EP (1)	EP1438049B1 (fr)
JP (1)	JP4418676B2 (fr)
KR (1)	KR100967599B1 (fr)
CN (1)	CN1283252C (fr)
AR (1)	AR036800A1 (fr)
AT (1)	ATE345799T1 (fr)
AU (1)	AU2002363369B2 (fr)
BR (1)	BR0213325A (fr)
CA (1)	CA2462374C (fr)
CY (1)	CY1106335T1 (fr)
DE (1)	DE60216310T2 (fr)
EA (1)	EA007657B1 (fr)
ES (1)	ES2276980T3 (fr)
HR (1)	HRP20040325A2 (fr)
HU (1)	HUP0402332A3 (fr)
IL (1)	IL161347A0 (fr)
MX (1)	MXPA04003480A (fr)
MY (1)	MY139586A (fr)
NO (1)	NO20041681L (fr)
NZ (1)	NZ531733A (fr)
PL (1)	PL370371A1 (fr)
PT (1)	PT1438049E (fr)
UA (1)	UA75980C2 (fr)
WO (1)	WO2003039440A2 (fr)
ZA (1)	ZA200402816B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200403058A (en) *	2002-04-19	2004-03-01	Bristol Myers Squibb Co	Heterocyclo inhibitors of potassium channel function
CL2004000754A1 (es) *	2003-04-11	2005-02-25	Janssen Pharmaceutica Nv	Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central.
WO2005005478A2 (fr) *	2003-07-02	2005-01-20	Bayer Healthcare Ag	Diagnostics et traitements de maladies associees au recepteur opioide delta 1 (oprd1) couple a une proteine g
WO2005015242A1 (fr) *	2003-08-06	2005-02-17	Bayer Healthcare Ag	Agents diagnostiques et agents therapeutiques destines a des maladies associees au recepteur opioide kappa 1 (opkr1) couple aux proteines g
TW200633990A (en) *	2004-11-18	2006-10-01	Takeda Pharmaceuticals Co	Amide compound
EP2227466B1 (fr) *	2007-11-30	2011-04-20	Bayer Schering Pharma Aktiengesellschaft	Pipéridines à substitution hétéroaryl
DE102009014484A1 (de)	2009-03-23	2010-09-30	Bayer Schering Pharma Aktiengesellschaft	Substituierte Piperidine
DE102009022896A1 (de)	2009-05-27	2010-12-02	Bayer Schering Pharma Aktiengesellschaft	Substituierte Piperidine
DE102009022894A1 (de)	2009-05-27	2010-12-02	Bayer Schering Pharma Aktiengesellschaft	Substituierte Piperidine
DE102009056387B9 (de) *	2009-10-30	2020-05-07	Osram Opto Semiconductors Gmbh	Kantenemittierender Halbleiterlaser mit einem Phasenstrukturbereich zur Selektion lateraler Lasermoden
HRP20250272T1 (hr)	2017-10-19	2025-04-25	Teijin Pharma Limited	Derivati benzimidazola i njihova uporaba
CN113209294B (zh) *	2020-02-05	2023-06-13	复旦大学	Dor激动剂在制备对抗肾脏纤维化药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT813416E (pt)	1995-03-06	2005-10-31	Interneuron Pharma	Reducao do volume de enfarte usando citicolina
WO1998007832A1 (fr)	1996-08-23	1998-02-26	Ludwig Institute For Cancer Research	Facteur d recombinant de croissance des cellules endotheliales vasculaires (vegf-d)
EP0977854A2 (fr)	1997-04-25	2000-02-09	Collateral Therapeutics	Formes tronquees de proteines apparentees au facteur vegf
US6103722A (en)	1997-07-23	2000-08-15	The Medical College Of Wisconsin Research Foundation Inc.	Ischemic preconditioning
GB2332373A (en) *	1997-12-19	1999-06-23	Merck & Co Inc	Treatment of coronary and/or peripheral ischemia using an antithrombotic agent and an angiogenesis promoter
BR9916371A (pt) *	1998-12-19	2001-09-18	Janssen Pharmaceutica Nv	Composto de espiro anti-histamìnico
EP1038872A1 (fr) *	1999-02-22	2000-09-27	Pfizer Products Inc.	Dérivés de 4-phényl-4-hétéroarylpiperdine comme ligands des récepteurs opioides
US6297256B1 (en) *	1999-06-15	2001-10-02	Neurogen Corporation	Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
BR0213327A (pt) *	2001-10-15	2004-10-13	Janssen Pharmaceutica Nv	Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìdos e sua aplicação como agonistas de delta opióides não-peptìdicos seletivos
FR2831166B1 (fr)	2001-10-18	2004-02-27	Sanofi Synthelabo	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant

2002
- 2002-10-10 NZ NZ531733A patent/NZ531733A/en not_active IP Right Cessation
- 2002-10-10 WO PCT/EP2002/011371 patent/WO2003039440A2/fr not_active Ceased
- 2002-10-10 AU AU2002363369A patent/AU2002363369B2/en not_active Ceased
- 2002-10-10 EP EP02799040A patent/EP1438049B1/fr not_active Expired - Lifetime
- 2002-10-10 CA CA2462374A patent/CA2462374C/fr not_active Expired - Lifetime
- 2002-10-10 KR KR1020047002380A patent/KR100967599B1/ko not_active Expired - Fee Related
- 2002-10-10 BR BR0213325-3A patent/BR0213325A/pt not_active Application Discontinuation
- 2002-10-10 HU HU0402332A patent/HUP0402332A3/hu unknown
- 2002-10-10 AT AT02799040T patent/ATE345799T1/de active
- 2002-10-10 ES ES02799040T patent/ES2276980T3/es not_active Expired - Lifetime
- 2002-10-10 US US10/492,778 patent/US7390822B2/en not_active Expired - Fee Related
- 2002-10-10 EA EA200400547A patent/EA007657B1/ru not_active IP Right Cessation
- 2002-10-10 PT PT02799040T patent/PT1438049E/pt unknown
- 2002-10-10 IL IL16134702A patent/IL161347A0/xx not_active IP Right Cessation
- 2002-10-10 PL PL02370371A patent/PL370371A1/xx not_active Application Discontinuation
- 2002-10-10 HR HR20040325A patent/HRP20040325A2/hr not_active Application Discontinuation
- 2002-10-10 CN CNB028202961A patent/CN1283252C/zh not_active Expired - Fee Related
- 2002-10-10 JP JP2003541732A patent/JP4418676B2/ja not_active Expired - Fee Related
- 2002-10-10 MX MXPA04003480A patent/MXPA04003480A/es active IP Right Grant
- 2002-10-10 DE DE60216310T patent/DE60216310T2/de not_active Expired - Lifetime
- 2002-10-10 UA UA20040503666A patent/UA75980C2/uk unknown
- 2002-10-11 AR ARP020103836A patent/AR036800A1/es unknown
- 2002-10-11 MY MYPI20023801A patent/MY139586A/en unknown
2004
- 2004-04-13 ZA ZA2004/02816A patent/ZA200402816B/en unknown
- 2004-04-23 NO NO20041681A patent/NO20041681L/no not_active Application Discontinuation
2007
- 2007-02-22 CY CY20071100249T patent/CY1106335T1/el unknown

Also Published As

Publication number	Publication date
US20050004170A1 (en)	2005-01-06
HUP0402332A2 (hu)	2005-02-28
CA2462374A1 (fr)	2003-05-15
KR20050035120A (ko)	2005-04-15
NO20041681L (no)	2004-04-23
CN1283252C (zh)	2006-11-08
PL370371A1 (en)	2005-05-16
CY1106335T1 (el)	2011-10-12
WO2003039440A2 (fr)	2003-05-15
EP1438049B1 (fr)	2006-11-22
MXPA04003480A (es)	2004-07-30
AU2002363369B2 (en)	2008-08-21
WO2003039440A3 (fr)	2003-12-18
AR036800A1 (es)	2004-10-06
KR100967599B1 (ko)	2010-07-05
HK1072562A1 (en)	2005-09-02
HRP20040325A2 (en)	2005-04-30
UA75980C2 (en)	2006-06-15
MY139586A (en)	2009-10-30
BR0213325A (pt)	2004-10-13
JP2005507943A (ja)	2005-03-24
US7390822B2 (en)	2008-06-24
ES2276980T3 (es)	2007-07-01
JP4418676B2 (ja)	2010-02-17
CN1568186A (zh)	2005-01-19
ZA200402816B (en)	2005-06-29
PT1438049E (pt)	2007-02-28
DE60216310D1 (de)	2007-01-04
EP1438049A2 (fr)	2004-07-21
HUP0402332A3 (en)	2009-07-28
NZ531733A (en)	2006-04-28
EA200400547A1 (ru)	2004-10-28
ATE345799T1 (de)	2006-12-15
CA2462374C (fr)	2011-01-18
EA007657B1 (ru)	2006-12-29
DE60216310T2 (de)	2007-06-21

Legal Events

Date	Code	Title
2010-11-30	FF	Patent granted
2010-11-30	KB	Patent renewed
2012-10-31	KB	Patent renewed
2016-09-29	KB	Patent renewed
2021-05-31	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
GB2420891B (en)	2006-07-26	Improved memory controller
EP1451173A4 (fr)	2005-10-26	Piperidines
IL161516A0 (en)	2004-09-27	Benzimidazoles useful as protein kinase inhibitors
IL195011A0 (en)	2009-08-03	Process for preparing piperidine derivatives
SI1686119T1 (sl)	2009-12-31	Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
IL165887A0 (en)	2006-01-15	Novel tetrahydropyridine derivatives as renin inhibitors
PL375220A1 (en)	2005-11-28	Piperidine derivatives
IL162765A0 (en)	2005-11-20	Piperidine derivatives
IL161347A0 (en)	2004-09-27	Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
PL365939A1 (en)	2005-01-24	4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
HUP0301967A3 (en)	2004-04-28	Method for raising rabbits
GB2385317B (en)	2004-03-31	Package for small articles
EP1412337A4 (fr)	2004-12-22	Composes azole en tant qu'agents antifongiques
TW547285U (en)	2003-08-11	Rack for wrench
TW585146U (en)	2004-04-21	Improved structure for vertical hydraulic chuck
TW566304U (en)	2003-12-11	Improved hanging rack structure for tool
SG106049A1 (en)	2004-09-30	Magazine for semiconductor package
GB0104583D0 (en)	2001-04-11	Piperidine derivatives
TW519944U (en)	2003-02-01	Improved structure for tool rack
SG117438A1 (en)	2005-12-29	Improved buffer for semiconductor structures
TW522976U (en)	2003-03-01	Improved structure for vase stop
TW567973U (en)	2003-12-21	Improved exhibiting rack structure for wrench
TW500029U (en)	2002-08-21	Improved structure for tool bag
TW497534U (en)	2002-08-01	Improved structure for tool box
TW547283U (en)	2003-08-11	Improved structure for tool box